NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
12 hedge funds and large institutions have $131K invested in NeuroMetrix, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
8% less funds holding
Funds holding: 13 → 12 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
62% less capital invested
Capital invested by funds: $340K → $131K (-$210K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.11K |
| 3 |
CA
CoreCap Advisors
Southfield,
Michigan
|
+$407 |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$38 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
-$108K |
| 2 |
Renaissance Technologies
New York
|
-$84K |
| 3 |
VF
Virtu Financial
New York
|
-$43K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.17K |
| 5 |
BlackRock
New York
|
-$202 |
NURO Hedge Fund Activity: Q1 2024 in Review
12 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2024, worth a combined $131K — down 62% from $340K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NURO and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was UBS Group, adding an estimated $7.1K. The largest seller was Cerity Partners, exiting entirely with an estimated $108K sold.
- 12 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2024, down from 13 in Q4 2023.
- Funds reported $131K of NeuroMetrix, Inc. Common Stock stock for Q1 2024, down 62% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q1 2024 and 4 closed out, a net change of -1 holder.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2024 was UBS Group, an estimated $7.1K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q1 2024 was Cerity Partners, an estimated $108K sold.
Based on aggregated 13F filings for Q1 2024.